NSF To Host Pharma Compliance to Performance Conference
NSF’s Compliance to Performance conference will look at two of the most pressing issues in global pharma: artificial intelligence and supply chain disruptions.
We are bringing together an exciting panel of speakers from industry, trade associations, regulatory bodies, and academia. Speakers include Martin Lush, a renowned industry veteran and globally regarded expert about AI advancements in pharma manufacturing, and Paul Fleming, Technical Director of the British Generic Manufacturers Association and British Biosimilars Association. Paul will be talking about supply chain shortages impacting the industry.
The conference will be hosted by Lynne Ensor, Senior Global Managing Director of NSF’s Pharma Biotech division. Lynne has enjoyed a long career with extensive experience, including fourteen years in senior roles with the USFDA.
The event takes place during World Quality Week and adopts the theme of Compliance to Performance.
Book your place today
How NSF Can Help You
What’s New with NSF
NSF Launches Protocol 549 for Glyphosate Reduction Claims
October 14, 2026P549 is the first standard globally that validates glyphosate reduction performance of water filtration systems and products.
NSF Welcomes Hanjun Kwon, Managing Director, APAC
September 14, 2026Experienced business leader to drive sustainable growth, organisational development and operational excellence across the Asia-Pacific region.
NSF Welcomes Nicole Parent Haughey to Board of Directors
September 10, 2026NSF's appointment of Nicole supports the organisation's continued focus on long-term growth and transformation.
NSF Launches Independent Certification Standard for Compact Products
August 25, 2026New third-party certification verifies products cutting materials and shipping impacts while maintaining safety and performance.